furosemide/digoxin topical gel CLS003
Term · Oncology and biomedicine · MLC-T-ONC-013790
A topical ionic contra-viral therapy (ICVT) gel-based formulation that combines furosemide, a sulfamoylanthranilic acid derivative and loop diuretic, and digoxin, a cardiac glycoside, with potential antiviral activity. Upon topical administration, furosemide interacts with the cell membrane ion co-transporter, Na+-K+-2Cl-co-transporter-1(NKCC1; SLC12A2) and digoxin reversibly inhibits the sodium/potassium-transporting ATPase, leading to a decrease in potassium influx. This may prevent the replication of certain DNA viruses including human papillomavirus (HPV), that rely on potassium for replication.
| Identifier | MLC-T-ONC-013790 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | digoxin-furosemide topical gel CLS003; ICVT product CLS003 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013790",
"term": "furosemide/digoxin topical gel CLS003",
"field": "Oncology and biomedicine",
"definition": "A topical ionic contra-viral therapy (ICVT) gel-based formulation that combines furosemide, a sulfamoylanthranilic acid derivative and loop diuretic, and digoxin, a cardiac glycoside, with potential antiviral activity. Upon topical administration, furosemide interacts with the cell membrane ion co-transporter, Na+-K+-2Cl-co-transporter-1(NKCC1; SLC12A2) and digoxin reversibly inhibits the sodium/potassium-transporting ATPase, leading to a decrease in potassium influx. This may prevent the replication of certain DNA viruses including human papillomavirus (HPV), that rely on potassium for replication.",
"synonyms": [
"digoxin-furosemide topical gel CLS003",
"ICVT product CLS003"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/furosemide-digoxin-topical-gel-cls003/"
}
Record 7,651 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.